Search

Your search keyword '"Wen, Jing-Yun"' showing total 146 results

Search Constraints

Start Over You searched for: Author "Wen, Jing-Yun" Remove constraint Author: "Wen, Jing-Yun"
146 results on '"Wen, Jing-Yun"'

Search Results

2. The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy

3. An overview of mouse models of hepatocellular carcinoma

5. Brain magnetic resonance imaging predictors in anti‐N‐methyl‐D‐aspartate receptor encephalitis

6. Research progress in preparation and application of hemicellulose-based hydrogels

7. Research progress in preparation and application of hemicellulose-based hydrogels

10. The facilitating effects of KRT80 on chemoresistance, lipogenesis, and invasion of esophageal cancer.

11. CD45− erythroid progenitor cells promote lymph node metastasis in gastric cancer by inducing a hybrid epithelial/mesenchymal state in lymphatic endothelial cells.

12. The potential oncogenic effect of tissue-specific expression of JC polyoma T antigen in digestive epithelial cells

14. Corrigendum to “ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3 [Cancer Letters 535 (2022) 215646]’’

15. ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3

16. The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy

19. Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP/VHL/HIF1α/VEGFA pathway

23. ebv-circRPMS1 Promotes the Progression of EBV-Associated Gastric Carcinoma via Sam68 Complex Dependent Activation of METTL3

26. Examination of artificial MiRNA mimics with centered-site complementarity for gene targeting.

28. Prognostic Value of Serum Apolipoprotein B to Apolipoprotein A-I Ratio in Hepatocellular Carcinoma Patients Treated with Transcatheter Arterial Chemoembolization: A Propensity Score-Matched Analysis

32. The Prognostic Value of aspartate aminotransferase to lymphocyte ratio and systemic immune-inflammation index for Overall Survival of Hepatocellular Carcinoma Patients Treated with palliative Treatments

34. Modified CLIP score with the albumin-bilirubin grade retains prognostic value in HBV-related hepatocellular carcinoma patients treated with trans-catheter arterial chemoembolization therapy

35. The Predictive Value of Albumin-to-Alkaline Phosphatase Ratio for Overall Survival of Hepatocellular Carcinoma Patients Treated with Trans-Catheter Arterial Chemoembolization Therapy

36. Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans‑arterial chemoembolization therapy

37. Serum Golgi protein 73 is a prognostic rather than diagnostic marker in hepatocellular carcinoma

38. Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma

39. Validation and ranking of seven staging systems of hepatocellular carcinoma

40. Stat3-siRNA inhibits the growth of gastric cancer in vitro and in vivo

41. Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization

42. Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma

43. Examination of Artificial MiRNA Mimics with Centered–Site Complementarity for Gene Targeting

44. Comparison of five staging systems in predicting the survival rate of patients with hepatocellular carcinoma undergoing trans-arterial chemoembolization therapy.

45. Staged Improvement in Awareness of Disease for Elderly Cancer Patients in Southern China

46. Alanine aminotransferase to hemoglobin ratio is an indicator for disease progression for hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization

47. MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells

49. Hepatitis B Virus DNA Negativity Acts as a Favorable Prognostic Factor in Hepatocellular Carcinoma Patients

50. Platelet-to-lymphocyte ratio acts as a prognostic factor for patients with advanced hepatocellular carcinoma

Catalog

Books, media, physical & digital resources